Mann-Whitney – Page 3 – Communicable Diseases Research

Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic

Observational Study

Published on 2020-12-012022-10-05
Journal: Medicina intensiva [Category] SARS, 임상,

[키워드] Admission age APACHE II arterial assisted ventilation Automatic Bacterial Care carried Characteristics Cohort Comorbidities complications COVID-19 Deceased Demographic variables experience Fisher exact test Frequency General population HFO high-flow oxygen therapy hospital hypertension IMV incidence Infection initial Insuficiencia respiratoria Invasive mechanical ventilation laboratory data lack males Mann-Whitney Mechanical mechanical ventilation medians obesity Oxygen therapy Oxygenation pandemic PaO parameters Patient patients patients with COVID-19 Pneumonia Prognostic marker required respiratory Respiratory failure severity single-center SOFA survivor the patient the SARS-CoV-2 turn variables Ventilación mecánica Ventilation was used Wilcoxon test with COVID-19
[DOI] 10.1016/j.medin.2020.05.018 PMC 바로가기 [Article Type] Observational Study

COVID-19 Impact on Lymphoma Patients’ Clinical Outcomes – an Observational Cohort Study

Conference abstract

Published on 2020-11-042022-10-05
Journal: Blood [Category] 유전자 메커니즘,

[키워드] 30-Day mortality abnormality absolute neutrophil count active cancer advanced age age anti-CD20 therapy anti-CD20 treatment antibody Antibody test baseline board Cancer CD20 clinical clinical information Clinical outcome CLL cohort study conducted continuous variable contributing to cough COVID-19 COVID-19 diagnosis COVID-19 infection COVID-19 PCR test COVID-19 related mortality CRP current death demographic determine diabete diabetes Diagnosis died distribution DLBCL download Electronic health record equity ferritin Fever figure funding higher risk hypertension IgG antibody immune Immunity Impact indolent Infection Infinity IQR Kaplan-Meier method Kite Lymphocyte count lymphoma male Mann-Whitney marker mechanical ventilation median median age median time multicenter naïve number of comorbidities Observational cohort study Other outcome parameter Patient patients patients required hospitalization patients treated patients with SARS-CoV-2 Pearson performance status presenting symptom receive Regional repeated reported required retrospective risk Sample size SARS-CoV2 Seattle seronegative seropositive Shortness of breath shown significantly lower significantly more speaker subtype survival T cell tested the median therapy treated treated patient Treatment university variable variables viral shedding was obtained while with COVID-19
[DOI] 10.1182/blood-2020-141871 [Article Type] Conference abstract